268 related articles for article (PubMed ID: 37508421)
21. Identification of molecular patterns and diagnostic biomarkers in juvenile idiopathic arthritis based on the gene expression of m
Zhang S; Qin J; Zhao Y; Wang J; Tian Z
Front Pediatr; 2022; 10():930119. PubMed ID: 36160781
[TBL] [Abstract][Full Text] [Related]
22. Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes.
Schulert GS; Fall N; Harley JB; Shen N; Lovell DJ; Thornton S; Grom AA
Arthritis Rheumatol; 2016 Sep; 68(9):2300-13. PubMed ID: 27014994
[TBL] [Abstract][Full Text] [Related]
23. Differentially Expressed Inflammation-Regulating MicroRNAs in Oligoarticular Juvenile Idiopathic Arthritis.
McAlpine SM; Roberts SE; Hargreaves BKV; Bullock C; Ramsey S; Stringer E; Lang B; Huber A; György B; Erdélyi F; Issekutz TB; Dérfalvi B
J Rheumatol; 2023 Feb; 50(2):227-235. PubMed ID: 35840148
[TBL] [Abstract][Full Text] [Related]
24. Abatacept in difficult-to-treat juvenile idiopathic arthritis.
Kuemmerle-Deschner JB; Benseler S
Biologics; 2008 Dec; 2(4):865-74. PubMed ID: 19707464
[TBL] [Abstract][Full Text] [Related]
25. Current Therapeutic Options for the Treatment of Juvenile Idiopathic Arthritis.
Saougou IG; Markatseli TE; Voulgari PV; Drosos AA
Curr Rheumatol Rev; 2021; 17(1):41-57. PubMed ID: 32942977
[TBL] [Abstract][Full Text] [Related]
26. Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind.
Scott C; Chan M; Slamang W; Okong'o L; Petty R; Laxer RM; Katsicas MM; Fredrick F; Chipeta J; Faller G; Pileggi G; Saad-Magalhaes C; Wouters C; Foster HE; Kubchandani R; Ruperto N; Russo R
Clin Rheumatol; 2019 Feb; 38(2):563-575. PubMed ID: 30267356
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry.
van Straalen JW; de Roock S; Giancane G; Alexeeva E; Koskova E; Mesa-Del-Castillo Bermejo P; Zulian F; Civino A; Montin D; Wulffraat NM; Ruperto N; Swart JF;
Pediatr Rheumatol Online J; 2022 Nov; 20(1):103. PubMed ID: 36401230
[TBL] [Abstract][Full Text] [Related]
28. Emerging therapies for juvenile arthritis: agents in early clinical trials.
Rosina S; Giancane G; Ruperto N
Expert Opin Investig Drugs; 2022 Oct; 31(10):1109-1124. PubMed ID: 36066506
[TBL] [Abstract][Full Text] [Related]
29. Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis.
Vastert S; Prakken B
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):229-46. PubMed ID: 24974060
[TBL] [Abstract][Full Text] [Related]
30. The human microbiome and juvenile idiopathic arthritis.
Verwoerd A; Ter Haar NM; de Roock S; Vastert SJ; Bogaert D
Pediatr Rheumatol Online J; 2016 Sep; 14(1):55. PubMed ID: 27650128
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the time of patients' admission to the tertiary pediatric rheumatology center for juvenile idiopathic arthritis.
Kurt T; Tekin ZE; Çelikel E; Aydın F; Tekgöz N; Sezer M; Karagöl C; Coşkun S; Kaplan MM; Öner N; Polat MC; Sezer S; Acar B
ARP Rheumatol; 2022; 1(4):286-292. PubMed ID: 36617311
[TBL] [Abstract][Full Text] [Related]
32. Role of Micro RNAs in the Pathogenesis of Rheumatoid Arthritis: Novel Perspectives Based on Review of the Literature.
Chen XM; Huang QC; Yang SL; Chu YL; Yan YH; Han L; Huang Y; Huang RY
Medicine (Baltimore); 2015 Aug; 94(31):e1326. PubMed ID: 26252320
[TBL] [Abstract][Full Text] [Related]
33. Family resilience and adaptive coping in children with juvenile idiopathic arthritis: protocol for a systematic review.
Saetes S; Hynes L; McGuire BE; Caes L
Syst Rev; 2017 Nov; 6(1):221. PubMed ID: 29096708
[TBL] [Abstract][Full Text] [Related]
34. Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis.
Tu ZQ; Xue HY; Chen W; Cao LF; Zhang WQ
Rheumatol Int; 2017 Mar; 37(3):423-434. PubMed ID: 27866247
[TBL] [Abstract][Full Text] [Related]
35. JNK Pathway-Associated Phosphatase as a Serum Marker for Disease Activity and Treatment Outcome of Juvenile Idiopathic Arthritis.
Zhu S; Lv H; Luo Y; Huang Q; Shen J
Tohoku J Exp Med; 2021 Jan; 253(1):19-28. PubMed ID: 33441511
[TBL] [Abstract][Full Text] [Related]
36. Acute monoarthritis in young children: comparing the characteristics of patients with juvenile idiopathic arthritis versus septic and undifferentiated arthritis.
Thomas M; Bonacorsi S; Simon AL; Mallet C; Lorrot M; Faye A; Dingulu G; Caseris M; Boneca IG; Aupiais C; Meinzer U
Sci Rep; 2021 Feb; 11(1):3422. PubMed ID: 33564018
[TBL] [Abstract][Full Text] [Related]
37. [Juvenile idiopathic arthritis: from biomarker to treatment].
Nusman CM; van den Berg JM; Schonenberg-Meinema D; Maas M; ten Cate R; Kuijpers TW
Ned Tijdschr Geneeskd; 2013; 157(45):A6391. PubMed ID: 24191923
[TBL] [Abstract][Full Text] [Related]
38. Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
Ramanan AV; Guly CM; Keller SY; Schlichting DE; de Bono S; Liao R; Quartier P
Trials; 2021 Oct; 22(1):689. PubMed ID: 34627340
[TBL] [Abstract][Full Text] [Related]
39. Clinical features in 305 patients with juvenile idiopathic arthritis: A single center Turkish Study.
Ozdel S; Baglan E; Cakıcı EK; Yazılıtas F; Yücel H; Senel S; Bulbul M
Pediatr Int; 2021 Jun; 63(6):636-642. PubMed ID: 32969552
[TBL] [Abstract][Full Text] [Related]
40. Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook.
Selvestrel D; Lucafò M; Pugnetti L; Pagarin S; Moressa V; Pastore S; Taddio A; Stocco G; Decorti G
Expert Rev Clin Immunol; 2021 Oct; 17(10):1131-1142. PubMed ID: 34392756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
